W

hat does the cost of a drug say about society’s values? And what is the market willing to pay for?

That’s a loaded question, to be sure, but a new report from life sciences consultancy Trinity Partners tries to dissect the issue a bit.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.